Interesting title but there is NO EVIDENCE FOR TARGET ENGAGEMENT (e.g. D3/D2 receptor occupancy)!
Title: 'Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial.'
nature.com/articles/s41...